![Samuel Sternheim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Sternheim
Directeur Financier/CFO chez
Sapir Pharmaceuticals, Inc.
Profil
Samuel Sternheim is currently the Chief Financial Officer & Director at Sapir Pharmaceuticals, Inc. He previously worked as the CFO, Secretary, Treasurer & Director at Lode-Star Mining, Inc. in 2022.
Postes actifs de Samuel Sternheim
| Sociétés | Poste | Début |
|---|---|---|
Sapir Pharmaceuticals, Inc.
 Sapir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies in opiate and cocaine addiction, withdrawal, relapse & novel pharmaceutical formulations | Directeur Financier/CFO | 01/01/2015 |
Anciens postes connus de Samuel Sternheim
| Sociétés | Poste | Fin |
|---|---|---|
| FINTRADE SHERPA, INC. | Directeur Financier/CFO | 06/10/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
FinTrade Sherpa, Inc.
 FinTrade Sherpa, Inc. Precious MetalsNon-Energy Minerals Engages in the acquisition and exploration of mining properties | Non-Energy Minerals |
Sapir Pharmaceuticals, Inc.
Sapir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies in opiate and cocaine addiction, withdrawal, relapse & novel pharmaceutical formulations | Health Technology |
